Medical Microbiology and immunology department- Faculty of Medicine, Minia University, Minia, Egypt.
Department of Pharmacology, Faculty of Medicine, Minia University, Minia, Egypt.
BMC Microbiol. 2023 Apr 20;23(1):112. doi: 10.1186/s12866-023-02856-3.
Resistance to antibiotics has increased steadily over time, thus there is a pressing need for safer alternatives to antibiotics. Current study aims to evaluate the influence of vitamin C as an antibacterial and anti-biofilm agent against uropathogenic E. coli (UPEC) strains. The expression of beta-lactamases and biofilm encoding genes among E. coli isolates before and after treating the isolates with sub MIC of vitamin C was analyzed by Real-time PCR. The in vivo assessment of the antibacterial and anti-biofilm effects of vitamin C against uropathogenic E. coli strains was done using a urinary tract infection (UTI) rat model.
The effective concentration of vitamin C that could inhibit the growth of most study isolates (70%) was 1.25 mg/ml. Vitamin C showed a synergistic effect with most of the studied antibiotics; no antagonistic effect was detected at all. Vitamin C showed an excellent anti-biofilm effect against studied isolates, where 43 biofilm-producing isolates were converted to non-biofilm at a concentration of 0.312 mg/ml. The expression levels of most studied genes were down-regulated after treatment of E. coli isolates with vitamin C. In vivo assessment of vitamin C in treating UTIs showed that vitamin C has a rapid curative effect as the comparable antibiotic. Administration of both vitamin C and nitrofurantoin at a lower dose for treatment of UTI in rats had a better effect.
Vitamin C as an antibacterial and anti-biofilm agent either alone or in combination with antibiotics could markedly improve UTI in experimental rats.
随着时间的推移,抗生素的耐药性稳步上升,因此迫切需要更安全的抗生素替代品。本研究旨在评估维生素 C 作为一种抗菌和抗生物膜剂对尿路致病性大肠杆菌 (UPEC) 菌株的影响。通过实时 PCR 分析了大肠杆菌分离株在亚 MIC 维生素 C 处理前后β-内酰胺酶和生物膜编码基因的表达。使用尿路感染 (UTI) 大鼠模型对维生素 C 对尿路致病性大肠杆菌菌株的体内抗菌和抗生物膜作用进行了评估。
能抑制大多数研究分离株(70%)生长的有效维生素 C 浓度为 1.25 mg/ml。维生素 C 与大多数研究的抗生素表现出协同作用;根本没有检测到拮抗作用。维生素 C 对研究分离株表现出极好的抗生物膜作用,其中 43 个产生物膜的分离株在 0.312 mg/ml 的浓度下转化为非生物膜。在用维生素 C 处理大肠杆菌分离株后,大多数研究基因的表达水平下调。维生素 C 治疗尿路感染的体内评估表明,维生素 C 具有快速的治疗效果,与可比抗生素相当。维生素 C 与呋喃妥因联合使用,或用于治疗 UTI 的剂量较低,对大鼠的治疗效果更好。
维生素 C 作为一种抗菌和抗生物膜剂,无论是单独使用还是与抗生素联合使用,都可以显著改善实验大鼠的尿路感染。